Ultragenyx Pharmaceutical Company

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Investors

Industry: PharmTech
Funding Status: IPO
Estimated Revenue: $10M to $50M
Headquarters: Novato, California, United States
Technology: Immunotherapy
Founded Date: 2010
Employee Number: 501-1000
Register and Claim Ownership